BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35116246)

  • 1. Identification of potential biomarkers and available drugs for oral squamous cell carcinoma.
    Zhang Z; Bi F; Zhang Z; Tian W; Guo W
    Transl Cancer Res; 2021 Jan; 10(1):141-151. PubMed ID: 35116246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological information analysis of differentially expressed genes in oral squamous cell carcinoma tissues in GEO database.
    Wang Y; Fan H; Zheng L
    J BUON; 2018; 23(6):1662-1670. PubMed ID: 30610792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Xu Z; Jiang P; He S
    Med Sci Monit; 2019 Dec; 25():9216-9226. PubMed ID: 31794546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction.
    Wu HT; Chen WT; Li GW; Shen JX; Ye QQ; Zhang ML; Chen WJ; Liu J
    Front Genet; 2019; 10():1328. PubMed ID: 32038705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes correlated with oral squamous cell carcinoma.
    Lin T; Zhang B; He H
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S675-S679. PubMed ID: 30249886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
    Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
    Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening pathogenic genes in oral squamous cell carcinoma based on the mRNA expression microarray data.
    Ding Y; Liu P; Zhang S; Tao L; Han J
    Int J Mol Med; 2018 Jun; 41(6):3597-3603. PubMed ID: 29512771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a six-gene prognostic signature for oral squamous cell carcinoma.
    Wang J; Wang Y; Kong F; Han R; Song W; Chen D; Bu L; Wang S; Yue J; Ma L
    J Cell Physiol; 2020 Mar; 235(3):3056-3068. PubMed ID: 31538341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis and identification of nine-gene signature associated to oral squamous cell carcinoma pathogenesis.
    Yadav M; Pradhan D; Singh RP
    3 Biotech; 2021 May; 11(5):215. PubMed ID: 33928003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of transcriptome expression profiling data in oral leukoplakia and early and late‑stage oral squamous cell carcinoma.
    Yao L; Guo B; Wang J; Wu J
    Oncol Lett; 2023 Apr; 25(4):156. PubMed ID: 36936021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.
    Yang B; Zhang M; Luo T
    Front Genet; 2020; 11():517362. PubMed ID: 33193601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
    Dong S; Liang J; Zhai W; Yu Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma.
    Ghosal S; Banerjee S
    Med Oncol; 2022 Feb; 39(5):53. PubMed ID: 35150335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis.
    Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G
    Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive analysis of candidate gene signatures in oral squamous cell carcinoma.
    Li X; Sun R; Geng X; Wang S; Zen D; Pei J; Yang J; Fan Y; Jiang H; Yang P; Li C
    Neoplasma; 2017; 64(2):167-174. PubMed ID: 28043142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.